Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/22306
Full metadata record
DC FieldValueLanguage
dc.contributor.authorTsimihodimos, V.en
dc.contributor.authorMitrogianni, Z.en
dc.contributor.authorElisaf, M. S.en
dc.date.accessioned2015-11-24T19:23:26Z-
dc.date.available2015-11-24T19:23:26Z-
dc.identifier.issn1874-1924-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/22306-
dc.rightsDefault Licence-
dc.titleDyslipidemia associated with chronic kidney diseaseen
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.primary10.2174/1874192401105010041-
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/21643500-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2011-
heal.abstractCardiovascular disease is a major cause of morbidity and mortality in patients with impaired renal function. Dyslipidemia has been established as a well-known traditional risk factor for cardiovascular disease (CVD) in the general population and it is well known that patients with chronic kidney disease (CKD) exhibit significant alterations in lipoprotein metabolism. In this review, the pathogenesis and treatment of CKD-induced dyslipidemia are discussed. Studies on lipid abnormalities in predialysis, hemodialysis and peritoneal dialysis patients are analyzed. In addition, the results of the studies that tested the effects of the hypolipidemic drugs on cardiovascular morbidity and mortality in patients with CKD are reported.en
heal.journalNameOpen Cardiovasc Med Jen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Elisaf-2011-dyslipidemia associated with.pdf136.45 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons